Previous 10 | Next 10 |
India Globalization Capital (IGC) +128% announces issuance of Patent for the treatment of Alzheimer’s disease using THCPainReform (PRFX) +51%.ImmunoPrecise Antibodies IPA +41% highlights new data from TATX-03 SARS-CoV-2 Delta studySequential Brands (SQBG) +28%.NeuroMetri...
India Globalization Capital (IGC) soars 152% premarket after announcing that the USPTO issued a patent (#11,065,225) for the treatment of Alzheimer’s disease ((AD)) entitled “Ultra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimer’s Di...
India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office (“USPTO”) issued a patent (#11,065,225) for the treatment of Alzheimer’s disease entitled ȁ...
10 Penny Stocks to Watch With AMC in Focus With July in full swing, there is plenty to consider when looking for penny stocks to buy. We’ve covered what factors are in play right now numerous times in the past few weeks. But if you’re unfamiliar, here’s a short summ...
Gainers: India Globalization Capital (IGC) +21%.SGOCO Group (SGOC) +16%.Aspen Aerogels (ASPN) +13%.Franklin Covey (FC) +11%.R. R. Donnelley & Sons (RRD) +8%.Losers: Global Internet of People (SDH) -14%.TuSimple Holdings (TSP) -11%.Lightbridge (LTBR) -8%.CBAK Energy Technology (CBAT) ...
Marin Software Incorporated (MRIN) +63% on new InstaCart Ad Integration.India Globalization Capital (IGC) +22% on Alzheimer’s drug trial update.GTT Communications (GTT) +21%.Aravive, Inc. (ARAV) +20% on early-stage kidney cancer study data.Arcus Biosciences (RCUS) +19%...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome to another busy day of trading, investor! We’re starting the day off with a look at the biggest pre-market stock movers for Thursday. Source: f11photo/Shutterstock.com Let’s jump into those pre...
India Globalization Capital (IGC) jumps 37.2% premarket after completing Cohort 3 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol ((THC))-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s d...
India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces today it has completed Cohort 3 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intende...
India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the Fiscal Year Ended March 31, 2021. Revenue was approximately $898 thousand and $4.1 million for Fiscal 2021 and Fiscal 2020, respectively. In Fiscal 2021, the Company’s revenues were...
News, Short Squeeze, Breakout and More Instantly...
India Globalization Capital Inc. Company Name:
IGC Stock Symbol:
NYSE Market:
Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associ...
As the Benzinga Cannabis Capital Conference gets underway in Florida, gathering top CEOs, investors and leaders in the cannabis industry, let'...
Wednesday, IGC Pharma Inc (NYSE:IGC) announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation i...